210 related articles for article (PubMed ID: 19245429)
21. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
22. CCL3 (MIP-1alpha) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2.
Ottonello L; Montecucco F; Bertolotto M; Arduino N; Mancini M; Corcione A; Pistoia V; Dallegri F
Cell Signal; 2005 Mar; 17(3):355-63. PubMed ID: 15567066
[TBL] [Abstract][Full Text] [Related]
23. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.
Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J
Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559
[TBL] [Abstract][Full Text] [Related]
24. Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.
Caron C; Spring K; Laramée M; Chabot C; Cloutier M; Gu H; Royal I
Cell Signal; 2009 Jun; 21(6):943-53. PubMed ID: 19233262
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil function and cytokine-specific signaling in chronic neutrophilic leukemia.
Uemura Y; Taguchi T; Kubota T; Saito T; Bandobashi K; Yokoyama A
Int J Lab Hematol; 2009 Feb; 31(1):36-47. PubMed ID: 18241214
[TBL] [Abstract][Full Text] [Related]
26. Characterization and development of a peptide substrate-based phosphate transfer assay for the human vascular endothelial growth factor receptor-2 tyrosine kinase.
Zhao G; Peery RB; Yingling JM
Anal Biochem; 2007 Jan; 360(2):196-206. PubMed ID: 17141171
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors.
Guthridge MA; Stomski FC; Thomas D; Woodcock JM; Bagley CJ; Berndt MC; Lopez AF
Stem Cells; 1998; 16(5):301-13. PubMed ID: 9766809
[TBL] [Abstract][Full Text] [Related]
28. Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2.
Alonso V; de Gortázar AR; Ardura JA; Andrade-Zapata I; Alvarez-Arroyo MV; Esbrit P
J Cell Physiol; 2008 Dec; 217(3):717-27. PubMed ID: 18651620
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of TNFalpha and GM-CSF induced activation of P38 MAPK in neutrophils and eosinophils.
ten Hove W; Houben LA; Raaijmakers JA; Bracke M; Koenderman L
Mol Immunol; 2007 Mar; 44(9):2492-6. PubMed ID: 17126905
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
[TBL] [Abstract][Full Text] [Related]
31. An increase in the expression and total activity of endogenous p60(c-Src) in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1).
Horn S; Meyer J; Stocking C; Ostertag W; Jücker M
Oncogene; 2003 Oct; 22(46):7170-80. PubMed ID: 14562045
[TBL] [Abstract][Full Text] [Related]
32. Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation.
Noman AS; Koide N; Khuda II; Dagvadorj J; Tumurkhuu G; Naiki Y; Komatsu T; Yoshida T; Yokochi T
Biochem Biophys Res Commun; 2008 Oct; 374(4):683-7. PubMed ID: 18662673
[TBL] [Abstract][Full Text] [Related]
33. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
34. Opposing effects of sodium salicylate and haematopoietic cytokines IL-3, IL-5 and GM-CSF on mitogen-activated protein kinases and apoptosis of EoL-1 cells.
Wong CK; Zhang JP; Lam CW; Ho CY; Hjelm NM
Immunol Invest; 1999; 28(5-6):365-79. PubMed ID: 10574634
[TBL] [Abstract][Full Text] [Related]
35. GM-CSF enhances a CpG-independent pathway of neutrophil activation triggered by bacterial DNA.
Fuxman Bass JI; Alvarez ME; Gabelloni ML; Vermeulen ME; Amaral MM; Geffner JR; Trevani AS
Mol Immunol; 2008 Nov; 46(1):37-44. PubMed ID: 18701168
[TBL] [Abstract][Full Text] [Related]
36. PI3-kinase activation by GM-CSF in endothelium is upstream of Jak/Stat pathway: role of alphaGMR.
Dhar-Mascareno M; Pedraza A; Golde DW
Biochem Biophys Res Commun; 2005 Nov; 337(2):551-6. PubMed ID: 16202975
[TBL] [Abstract][Full Text] [Related]
37. Growth factors G-CSF and GM-CSF differentially preserve chemotaxis of neutrophils aging in vitro.
Wolach B; van der Laan LJ; Maianski NA; Tool AT; van Bruggen R; Roos D; Kuijpers TW
Exp Hematol; 2007 Apr; 35(4):541-50. PubMed ID: 17379064
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
39. Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia.
Barbarroja N; Torres LA; Luque MJ; Carretero RM; Valverde-Estepa A; Lopez-Sanchez LM; Rodriguez-Ariza A; Velasco F; Torres A; López-Pedrera C
Exp Hematol; 2009 Jun; 37(6):679-91. PubMed ID: 19463770
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil-activating activity and platelet-activating factor synthesis in cytokine-stimulated endothelial cells: reduced activity in growth-arrested cells.
Takahashi T; Nishizawa Y; Hato F; Shintaku H; Maeda N; Fujiwara N; Inaba M; Kobayashi K; Kitagawa S
Microvasc Res; 2007 Jan; 73(1):29-34. PubMed ID: 17027041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
